EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults

Margaret D Weiss iD, Jeffrey H Newcorn, Pratap Chokka, Marc Cataldo iD, Sailaja Bhaskar, Graeme A E Donnelly iD

Journal of Attention Disorders · 2026-12 · 30 (12) · 1471-1481

DOI: 10.1177/10870547261440452 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Attention Disorders, online erschienen am 05.05.2026. Verfasst von Margaret D Weiss und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Health Alliance, MA, USA. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Methylphenidate. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Purdue Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this analysis was to describe the effects of methylphenidate-mediated symptom improvement on functional impairments in adults with ADHD.

Methods

This is an exploratory study of self-reported functional impairment on the Weiss Functional Impairment Rating Scale (WFIRS-S) in 351 ADHD adults treated in a forced dose, double blind (DB), randomized, parallel clinical trial of a 16-hr methylphenidate stimulant (PRC-063) for 4 weeks followed by open-label (OL; N = 147) for 6 months.

Results

During the 4-week DB period, there was a statistically significant response to medication versus placebo in the WFIRS-S domain of “work.” Forty percent of DB subjects, assigned a random dose of medication, showed functional improvement as defined by the Minimal Clinical Important Differences (MCID) of the WFIRS. At the end of DB, one third of subjects had scores below symptomatic and functional impairment thresholds and two thirds by the end of OL. Although the OL period was uncontrolled, when all subjects had been dose optimized with sufficient time for functional impairment to manifest, all WFIRS functional domains showed clinically-relevant improvements from baseline to end of the 6-month OL ( p < .0001). There was a fair-to-moderate correlation between change in symptoms and change in function, but ADHD symptoms were about twice as sensitive to change. The strongest predictor of improvement in function was greater improvement in ADHD symptoms. Younger age predicted greater functional impairment.

Conclusion

This study of the relationship between change in symptoms and functional outcome illustrates that improvement in symptoms may be associated with an almost cotemporaneous improvement in function, that increases over time. Identification of subjects who are symptom responders with residual functional impairment suggests the need for additional intervention to target residual functional difficulty. Further research needs to replicate this methodology using an individually dose optimized design to demonstrate full potential for change and to confirm the domains of functioning in adults with ADHD that are most responsive to stimulant treatment. Clinical Trial Registration: https://clinicaltrials.gov/study/NCT02139124 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsMethylphenidateHumansDouble-Blind MethodFemaleAdultMaleTreatment OutcomeMiddle AgedYoung Adult

Stichwörter der Autor:innen

ADHDadultclinical responsefunctional impairmentstimulant

Substanzen

Central Nervous System StimulantsMethylphenidate

Autor:innen und Institutionen

  • Cambridge Health Alliance, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • The Chokka Centre for Integrative Health, Edmonton, AB, Canada.
  • Purdue Pharma L.P., Stamford, CT, USA.
  • Imbrium Therapeutics L.P, Stamford, CT, USA.

ORCID-Profile: Margaret D Weiss, Marc Cataldo, Graeme A E Donnelly

Förderung

  • Purdue Pharma

Zitieren

APA

Weiss, M. D., Newcorn, J. H., Chokka, P., Cataldo, M., Bhaskar, S., & Donnelly, G. A. E. (2026). An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults. Journal of Attention Disorders, 30(12), 1471-1481. https://doi.org/10.1177/10870547261440452

Vancouver

Weiss MD, Newcorn JH, Chokka P, Cataldo M, Bhaskar S, Donnelly GAE. An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults. Journal of Attention Disorders. 2026;30(12):1471-1481. doi:10.1177/10870547261440452

BibTeX
@article{Weiss2026,
  author = {Weiss, Margaret D and Newcorn, Jeffrey H and Chokka, Pratap and Cataldo, Marc and Bhaskar, Sailaja and Donnelly, Graeme A E},
  title = {An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults},
  journal = {Journal of Attention Disorders},
  year = {2026},
  volume = {30},
  number = {12},
  pages = {1471--1481},
  doi = {10.1177/10870547261440452}
}
Kostenlos starten →